SPOTLIGHT: Stada buys Russian pharma group


German drug maker Stada has snapped up the Russian pharma group Makiz for €125 million. Already active in the Russian market through its Nizhfarm and Hemofarm units, Stada will gain access to Makiz's production and development facilities. Makiz also has some 50 off-patent products, about half of which are sold as branded drugs. Report

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

North Korean hackers were accused of posing as corporate recruiters in a scheme to breach AstraZeneca's computer systems and steal COVID-19 research.

The FDA has delayed its review of Revance's frown-line injection candidate after it failed to inspect a key manufacturing facility on time.

McKinsey & Company helped guide Purdue's strategy for years and pitched the idea of rebates to distributors for overdoses, according to the NYT.